Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
PLXND1 Biologics Sequence Review Report 2026: Plexin-D1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PLXND1 Biologics Sequence Review Report 2026: Plexin-D1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PLXND1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PLXNC1 Biologics Sequence Review Report 2026: Plexin-C1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PLXNC1 Biologics Sequence Review Report 2026: Plexin-C1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PLXNC1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PLXNB3 Biologics Sequence Review Report 2026: Plexin-B3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PLXNB3 Biologics Sequence Review Report 2026: Plexin-B3 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PLXNB3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PLXNB2 Biologics Sequence Review Report 2026: Plexin-B2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PLXNB2 Biologics Sequence Review Report 2026: Plexin-B2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PLXNB2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PLXNA4 Biologics Sequence Review Report 2026: Plexin-A4 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PLXNA4 Biologics Sequence Review Report 2026: Plexin-A4 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PLXNA4 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PLXNA3 Biologics Sequence Review Report 2026: Plexin-A3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PLXNA3 Biologics Sequence Review Report 2026: Plexin-A3 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PLXNA3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PLXNA2 Biologics Sequence Review Report 2026: Plexin-A2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PLXNA2 Biologics Sequence Review Report 2026: Plexin-A2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PLXNA2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PLXNA1 Biologics Sequence Review Report 2026: Plexin-A1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PLXNA1 Biologics Sequence Review Report 2026: Plexin-A1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PLXNA1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PECAM1 Biologics Sequence Review Report 2026: Platelet endothelial cell adhesion molecule Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PECAM1 Biologics Sequence Review Report 2026: Platelet endothelial cell adhesion molecule Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PECAM1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
P2RY14 Biologics Sequence Review Report 2026: P2Y purinoceptor 14 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
P2RY14 Biologics Sequence Review Report 2026: P2Y purinoceptor 14 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of P2RY14 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
P2RY13 Biologics Sequence Review Report 2026: P2Y purinoceptor 13 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
P2RY13 Biologics Sequence Review Report 2026: P2Y purinoceptor 13 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of P2RY13 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
P2RY12 Biologics Sequence Review Report 2026: P2Y purinoceptor 12 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
P2RY12 Biologics Sequence Review Report 2026: P2Y purinoceptor 12 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of P2RY12 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →